Ataxia-telangiectasia: future prospects

Area of Science:

• Genetics and Molecular Biology
• Cellular Biology
• Biochemistry

Background:

• Ataxia-telangiectasia (A-T) is an autosomal recessive disorder caused by mutations in the ATM gene.
• The ATM kinase is crucial for the DNA damage response (DDR), regulating cell-cycle checkpoints, DNA repair, and cell fate.
• ATM also plays roles in nervous system function, immune response, and germ cell maturation.

Purpose of the Study:

• To provide a comprehensive overview of the ATM gene's function and its role in Ataxia-telangiectasia.
• To discuss the current understanding of A-T's multi-systemic effects, including immunodeficiency and infertility.
• To review potential therapeutic strategies for A-T, including emerging treatments and challenges.

Main Methods:

• Literature review of ATM gene function and Ataxia-telangiectasia research.
• Analysis of the DNA damage response pathways involving ATM.
• Exploration of current and potential therapeutic interventions.

Main Results:

• ATM is a central regulator of the DDR, essential for maintaining genome integrity after double-strand breaks.
• Defects in ATM lead to multi-systemic consequences in A-T patients, including neurological, immunological, and reproductive issues.
• ATM dysfunction is linked to increased oxidative stress sensitivity and potentially influences lifespan.

Conclusions:

• While no cure exists, therapies like glucocorticoids and histone deacetylase inhibitors show promise in managing A-T symptoms.
• Gene therapy presents a future possibility but faces delivery challenges, particularly across the blood-brain barrier.
• Further research into ATM's diverse functions may uncover novel therapeutic targets for A-T and related disorders.